Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

SKIMS PHARMACEUTICALS

Pharmaceutical manufacturer · Faisalabad · Pakistan

Pakistan pharmaceutical manufacturer specializing in branded generics across syrups, tablets, capsules, sachets and dry-powder suspensions.

Sourced corporate profile Corporate identity fields are source-tracked; portfolio, price and competitor intelligence remains independently calculated by MedInfoBase.
Official website ↗ Official contact ↗
ShareSend this page
Evidence & freshness

What is sourced, and how recent is it?

Public-source corporate details
Latest regulatory-source observation22 Sep 2026Newest linked source record observed by MedInfoBase
Latest portfolio source check22 Sep 2026Latest source-check date across this published portfolio
Latest effective price date23 Dec 2025Newest effective date among published current price records
Corporate profile evidence4 sourcesCorporate source details checked 16 Aug 2026

Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.

Regulatory & corporate identity

Company profile

Public-source corporate details
Company type
Pharmaceutical manufacturer
Address
10-B, Value Addition City, Khurianwala, Faisalabad 38000, Pakistan · 38000
Phone
+92 41 8507350
Official contact
Contact page ↗
Corporate source details checked
16 Aug 2026
Corporate profile completeness
75%
DRAP manufacturing licenceAs published by the DRAP Licensing Division. DRAP issues this list for stakeholder review and states it is not a reference for litigation, claims or citation.
Formulation 000830 Skims Pharmaceuticals. · Punjab
Source-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000830 37 linked products · source seen 22 Sep 2026 View source ↗
Corporate profile source ledger Contact Page Url source ↗ Logo Source Url source ↗ Profile Source Url source ↗
Location intelligence

Company location

Google Maps
Location recorded

A sourced company location is recorded. Use the map link below for directions.

Open in Google Maps ↗
Intelligence snapshot

Portfolio at a glance

Not sales data · published MedInfoBase database view
Rx38public portfolio records represented
REG25unique registrations represented
IDX37indexed MedInfoBase presentations
SRC1additional source-observed presentations
R+0registry-only registrations
VER0registry-verified exact registrations
PKR36current validated price records
G15generic molecules in indexed catalogue
DF5dosage-form groups
TA4therapeutic areas
How to read these counts

RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.

PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.

IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.

Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.

Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.

Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.

Data coverage

How complete is this profile?

Current price coverage95%
public portfolio presentations with a validated current price
Official-source coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage97%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixSKIMS PHARMACEUTICALSShare of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/skims-pharmaceuticalsGenerated 23 Sep 2026Anti-infectives23 · 62%Pain & musculoskeletal7 · 19%Gastrointestinal & hepatology5 · 14%Vitamins, minerals & nutrition2 · 5%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioSKIMS PHARMACEUTICALSDistribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/skims-pharmaceuticalsGenerated 23 Sep 202637presentationsSuspension17 · 46%Capsule11 · 30%Tablet6 · 16%Syrup2 · 5%Sachet1 · 3%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent Price Position

Shows whether safely comparable products are below, near or above the peer median unit price.

Equivalent Price PositionSKIMS PHARMACEUTICALSCurrent company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/skims-pharmaceuticalsGenerated 23 Sep 202636comparable productsBelow peer median25 · 69%Near peer median7 · 19%Above peer median4 · 11%Company median price position-14.3%Lowest-price equivalents3Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsSKIMS PHARMACEUTICALSCompanies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/skims-pharmaceuticalsGenerated 23 Sep 2026NovaMed Pharmaceuticals(Pvt.)Ltd14 shared93% overlapSemos Pharmaceuticals PVT LTD14 shared93% overlapM/s. Genix Pharma (Pvt) Ltd.13 shared87% overlapMediate Pharmaceutical Pvt Ltd13 shared87% overlapGlobal Pharmaceuticals (Pvt.) Ltd.13 shared87% overlapValor Pharmaceuticals13 shared87% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives23 products · 62%
Pain & musculoskeletal7 products · 19%
Gastrointestinal & hepatology5 products · 14%
Vitamins, minerals & nutrition2 products · 5%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Fluoroquinolone antibacterials8 products · 22%
Analgesics / NSAIDs7 products · 19%
Proton pump inhibitors5 products · 14%
Macrolide antibacterials5 products · 14%
Antifungals4 products · 11%
Nitroimidazole anti-infectives3 products · 8%
Vitamins / minerals / hematinics2 products · 5%
Tetracycline antibacterials1 products · 3%
Formulation footprint

Dosage forms

Suspension17 products
Capsule11 products
Tablet6 products
Syrup2 products
Sachet1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 ACHLOROmeprazole 5presentations 20 mg, 40 mg · Capsule #2 SKICINCiprofloxacin 5presentations 125 mg/5 mL, 250 MG, 250 mg/5 mL, 500 MG · Suspension, Tablet #3 SKICONFluconazole 4presentations 150 mg, 50 mg/5 mL · Capsule, Suspension #4 SKIFENIbuprofen 4presentations 100 mg, 100 mg/5 mL, 600 mg · Suspension, Sachet #5 DirazoleMetronidazole 3presentations 200 mg/5 mL · Suspension #6 SKIMOLParacetamol 3presentations 120 mg, 120 mg/5 mL · Suspension
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median2569% of comparable products
Near market median7within ±5% of median
Above market median411% of comparable products
Lowest-price equivalents3ties included
Company median price position -14.3% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
SKICON 150 mgFluconazole · Capsule · 1's PKR 128.70/capsule-51.3% vs market median SKICON 150 mgFluconazole · Capsule · 2's PKR 128.70/capsule-51.3% vs market median SKICON 150 mgFluconazole · Capsule · 4's PKR 128.71/capsule-51.3% vs market median SKIDOX 100 mgDoxycycline · Capsule · 10X10'S PKR 6.46/capsule-18.1% vs market median ACHLOR 20 mgOmeprazole · Capsule · 100'S PKR 16.35/capsule-17.0% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

NovaMed Pharmaceuticals(Pvt.)Ltd187 products · 62 generics 14shared generics Semos Pharmaceuticals PVT LTD104 products · 45 generics 14shared generics M/s. Genix Pharma (Pvt) Ltd.297 products · 97 generics 13shared generics Mediate Pharmaceutical Pvt Ltd236 products · 90 generics 13shared generics Global Pharmaceuticals (Pvt.) Ltd.224 products · 80 generics 13shared generics Valor Pharmaceuticals219 products · 97 generics 13shared generics
Regulatory & price activity

Observed database signals

Indexed registration numbers24Distinct registrations among indexed, published, presentation-validated products only
Verified price observations37
Products with a verified price37
Products with multiple price observations0
Source records with multiple versions37
Latest portfolio source check22 Sep 2026
Latest effective price date23 Dec 2025
Latest source observation22 Sep 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Company medicine portfolio

Medicine portfolio

25 unique registration(s) · 37 indexed presentation(s) · 1 additional source-observed presentation(s)

This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.

Reset
BrandGenericStrengthFormPackRegistrationSource-listed priceUnit pricePrice position
ACHLOR Omeprazole 20 mg Capsule 14's 091482 PKR 238.53 PKR 17.04/capsule 14% below median
ACHLOR Omeprazole 20 mg Capsule 10'S 091482 PKR 170.62 PKR 17.06/capsule 13% below median
ACHLOR Omeprazole 20 mg Capsule 100'S 091482 PKR 1,634.93 PKR 16.35/capsule 17% below median
ACHLOR Omeprazole 40 mg Capsule 14's 091483 PKR 414.11 PKR 29.58/capsule 15% below median
ACHLOR Omeprazole 40 mg Capsule 10'S 091483 PKR 296.50 PKR 29.65/capsule 14% below median
Dirazole Metronidazole 200 mg/5 mL Suspension 90ML 080431 PKR 79.50 PKR 0.88/mL Near median
Dirazole Metronidazole 200 mg/5 mL Suspension 400ML 080431 PKR 324.67 PKR 0.81/mL 12% below median
Dirazole Metronidazole 200 mg/5 mL Suspension 60ML 080431 PKR 53.01 PKR 0.88/mL Near median
LEVOKIM Levofloxacin 250 mg Tablet 10'S 091466 PKR 414.11 PKR 41.41/tablet 14% below median
LEVOKIM Levofloxacin 500 MG Tablet 10'S 091467 PKR 689.09 PKR 68.91/tablet 13% below median
SKICIN Ciprofloxacin 250 MG Tablet 10'S 091463 PKR 215.46 PKR 21.55/tablet 15% below median
SKICIN Ciprofloxacin 500 MG Tablet 10'S 091464 PKR 356.23 PKR 35.62/tablet 17% below median
SKICIN Ciprofloxacin 750 MG Tablet 10'S 091465 PKR 380.98 PKR 38.10/tablet Near median
SKICIN Ciprofloxacin 125 mg/5 mL Suspension 60 ML 121502 PKR 211.89 PKR 3.53/mL Near median
SKICIN Ciprofloxacin 250 mg/5 mL Suspension 60 ml 121503 PKR 342.01 PKR 5.70/mL 11% above median
SKICLAR Clarithromycin 125 MG/5 mL Suspension 60ML 091485 PKR 369.39 PKR 6.16/mL 17% below median
SKICLAR Clarithromycin 250 MG/5 mL Suspension 60ML 091486 PKR 609.57 PKR 10.16/mL 16% below median
SKICON Fluconazole 50 mg/5 mL Suspension 35ML 091460 PKR 347.85 PKR 9.94/mL 15% below median
SKICON Fluconazole 150 mg Capsule 4's 119608 PKR 514.82 PKR 128.71/capsule 51% below median
SKICON Fluconazole 150 mg Capsule 1's 119608 PKR 128.70 PKR 128.70/capsule 51% below median
SKICON Fluconazole 150 mg Capsule 2's 119608 PKR 257.40 PKR 128.70/capsule 51% below median
SKIDOX Doxycycline 100 mg Capsule 10X10'S 091451 PKR 646.02 PKR 6.46/capsule 18% below median
SKIFEN Ibuprofen 100 mg/5 mL Suspension 90ML 080436 PKR 96.84 PKR 1.08/mL 14% above median
SKIFEN Ibuprofen 100 mg Suspension 120ML 080436 PKR 129.12 PKR 1.08/mL 8% above median
SKIFEN Ibuprofen 100 mg/5 mL Suspension 400ML 080436 PKR 413.19 PKR 1.03/mL 9% above median
SKIFEN Ibuprofen 600 mg Sachet 4'S 096652 PKR 82.83 PKR 20.71/sachet 10% below median
SKIFER Iron polymaltose complex 50 mg/5 mL Syrup 60mL 080438 PKR 115.96 PKR 1.93/mL 17% below median
SKIFER Elemental Iron 50 mg Syrup 120mL 080438 PKR 220.31 PKR 1.84/mL No comparator
SKIMETHER Artemether + Lumefantrine 15 mg + 90 mg Dry suspension 60ML 091458 PKR 298.16 PKR 4.97/mL 15% below median
SKIMOL Paracetamol 120 mg Suspension 100ML 080437 PKR 104.84 PKR 1.05/mL Near median
SKIMOL Paracetamol 120 mg/5 mL Suspension 60ML 080437 PKR 62.91 PKR 1.05/mL Near median
SKIMOL Paracetamol 120 mg/5 mL Suspension 400ML 080437 PKR 402.59 PKR 1.01/mL Near median
SKIMOX Moxifloxacin 400 MG Tablet 5'S 091478 PKR 786.82 PKR 157.36/tablet 15% below median
SKITRAN SYP (sulphamethoxazole +Source observed Trimethoprim — — 50ML 080435Official source ↗ No indexed price — —
SKIZIT Azithromycin 250 mg Capsule 6'S 091450 PKR 253.44 PKR 42.24/capsule 15% below median
SKIZIT Azithromycin 250 mg Capsule 10'S 091450 PKR 422.40 PKR 42.24/capsule 15% below median
SKIZIT Azithromycin 200 mg/5 mL Suspension 15ML 091456 PKR 273.32 PKR 18.22/mL 17% below median
SKIZOL dry powder Linezolid 100 mg/5 mL Suspension 60ML 091461 PKR 579.76 PKR 9.66/mL 13% below median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.

Cite this record

Manufacturer record
MedInfoBase. (2026). SKIMS PHARMACEUTICALS — registered product portfolio in Pakistan [Data set]. MedInfoBase. Retrieved September 23, 2026, from https://medinfobase.com/company/skims-pharmaceuticals/
Download .RIS Download .BIB EndNote, Zotero, Mendeley, RefWorks

Records change over time. Please cite the access date so readers can locate the version you used.